• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Challenges of Studying Peripheral Vestibular Vertigo.

作者信息

Naples James G

机构信息

Division of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 110 Francis St, Suite 6E, Boston, MA, 02215, USA.

出版信息

Clin Drug Investig. 2020 Jan;40(1):99-100. doi: 10.1007/s40261-019-00871-9.

DOI:10.1007/s40261-019-00871-9
PMID:31676932
Abstract
摘要

相似文献

1
The Challenges of Studying Peripheral Vestibular Vertigo.研究外周性前庭性眩晕的挑战。
Clin Drug Investig. 2020 Jan;40(1):99-100. doi: 10.1007/s40261-019-00871-9.
2
Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial.西尼必利嗪 20 毫克和茶苯海明 40 毫克固定组合与双氢盐酸倍他司汀 16 毫克治疗外周性前庭眩晕患者的疗效和安全性：一项前瞻性、多国、多中心、双盲、随机、非劣效性临床试验。
Clin Drug Investig. 2019 Nov;39(11):1045-1056. doi: 10.1007/s40261-019-00858-6.
3
Authors' Reply to "The Challenges of Studying Peripheral Vestibular Vertigo".作者对《研究外周性前庭性眩晕的挑战》的回复。
Clin Drug Investig. 2020 Jan;40(1):101-102. doi: 10.1007/s40261-019-00872-8.
4
Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.比较桂利嗪和茶苯海明固定低剂量联合与倍他司汀治疗前庭神经炎的疗效：一项随机、双盲、非劣效性研究。
Clin Drug Investig. 2012 Jun 1;32(6):387-99. doi: 10.2165/11632410-000000000-00000.
5
Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials.西尼必利嗪 20 毫克与茶苯海明 40 毫克固定剂量组合治疗前庭性眩晕患者的疗效和安全性：一项随机、双盲、对照临床试验的个体患者数据荟萃分析。
Clin Drug Investig. 2022 Sep;42(9):705-720. doi: 10.1007/s40261-022-01184-0. Epub 2022 Jul 21.
6
A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders : a randomized, reference-controlled clinical study.桂利嗪/茶苯海明固定组合治疗前庭障碍所致急性眩晕患者：一项随机、对照临床研究
Clin Drug Investig. 2008;28(2):89-99. doi: 10.2165/00044011-200828020-00003.
7
Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate versus Betahistine in the Treatment of Otogenic Vertigo : A Double-Blind, Randomised Clinical Study.西尼必利嗪和茶苯海明固定组合与倍他司汀治疗耳源性眩晕的疗效和耐受性：一项双盲、随机临床试验。
Clin Drug Investig. 2005;25(6):377-89. doi: 10.2165/00044011-200525060-00003.
8
Treatment of vertebrobasilar insufficiency--associated vertigo with a fixed combination of cinnarizine and dimenhydrinate.用桂利嗪和茶苯海明固定复方治疗椎基底动脉供血不足相关性眩晕。
Int Tinnitus J. 2008;14(1):57-67.
9
Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study.桂利嗪与茶苯海明固定复方治疗急性单侧前庭功能丧失所致眩晕：一项双盲、随机、平行组临床研究。
Clin Ther. 2004 Jun;26(6):866-77. doi: 10.1016/s0149-2918(04)90130-0.
10
Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.桂利嗪和茶苯海明固定低剂量组合治疗眩晕的疗效和耐受性：一项为期4周的随机、双盲、活性药物和安慰剂对照、平行组门诊研究。
Clin Ther. 2007 Jan;29(1):84-98. doi: 10.1016/j.clinthera.2007.01.010.

引用本文的文献

1
Authors' Reply to "The Challenges of Studying Peripheral Vestibular Vertigo".作者对《研究外周性前庭性眩晕的挑战》的回复。
Clin Drug Investig. 2020 Jan;40(1):101-102. doi: 10.1007/s40261-019-00872-8.

本文引用的文献

1
Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial.西尼必利嗪 20 毫克和茶苯海明 40 毫克固定组合与双氢盐酸倍他司汀 16 毫克治疗外周性前庭眩晕患者的疗效和安全性：一项前瞻性、多国、多中心、双盲、随机、非劣效性临床试验。
Clin Drug Investig. 2019 Nov;39(11):1045-1056. doi: 10.1007/s40261-019-00858-6.
2
Voltage-Gated Calcium Channels: Key Players in Sensory Coding in the Retina and the Inner Ear.电压门控钙通道：视网膜和内耳感觉编码中的关键角色。
Physiol Rev. 2018 Oct 1;98(4):2063-2096. doi: 10.1152/physrev.00030.2017.
3
Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice.
桂利嗪和茶苯海明在医学实践中治疗眩晕的应用。
Wien Klin Wochenschr. 2016 May;128(9-10):341-7. doi: 10.1007/s00508-015-0905-5. Epub 2015 Dec 11.
4
Calcium-induced calcium release supports recruitment of synaptic vesicles in auditory hair cells.钙诱导的钙释放支持听觉毛细胞中突触小泡的募集。
J Neurophysiol. 2016 Jan 1;115(1):226-39. doi: 10.1152/jn.00559.2015. Epub 2015 Oct 28.
5
Diagnostic criteria for Menière's disease.梅尼埃病的诊断标准。
J Vestib Res. 2015;25(1):1-7. doi: 10.3233/VES-150549.
6
Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.比较桂利嗪和茶苯海明固定低剂量联合与倍他司汀治疗前庭神经炎的疗效：一项随机、双盲、非劣效性研究。
Clin Drug Investig. 2012 Jun 1;32(6):387-99. doi: 10.2165/11632410-000000000-00000.
7
Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study.桂利嗪与茶苯海明固定复方治疗急性单侧前庭功能丧失所致眩晕：一项双盲、随机、平行组临床研究。
Clin Ther. 2004 Jun;26(6):866-77. doi: 10.1016/s0149-2918(04)90130-0.
8
Use of nimodipine in the medical treatment of Menière's disease: clinical experience.尼莫地平在梅尼埃病药物治疗中的应用：临床经验
Am J Otol. 1996 Jul;17(4):577-80.
9
Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc.听力与平衡委员会梅尼埃病诊断和治疗评估指南。美国耳鼻咽喉-头颈基金会
Otolaryngol Head Neck Surg. 1995 Sep;113(3):181-5. doi: 10.1016/S0194-5998(95)70102-8.